Is non-contrast enhanced magnetic resonance imaging cost-effective for screening of hepatocellular carcinoma?
Genevieve Jingwen TanChau Hung LeeYan SunCher Heng TanPublished in: Singapore medical journal (2021)
Despite NCEMRI having a superior diagnostic accuracy, it is a less cost-effective strategy than US for HCC surveillance in the general at-risk population. Future local cost-effectiveness analyses should include stratifying surveillance methods with a variety of imaging techniques (US, NCEMRI, CEMRI) based on patients' risk profiles.